Skip to content
OpenCapital
Get started

CTEV CTEV EBIT

EBIT at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$10.6M-553%
Corvel logo
CorvelCRVL
$39.72M+19.2%
Phreesia logo
PhreesiaPHR
$6.75M+305%
UnitedHealth Group logo
UnitedHealth GroupUNH
——
ROP
Roper Technologies, Inc.ROP
——
Cognizant logo
CognizantCTSH
——

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B—
P/S0.6×—

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%—

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Calculated from CTEV’s reported figures.

$6.6Moperating income−$92.7Mincome before tax+$99.5Minterest expense=$6.64M

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's EBIT?
CTEV (CTEV) reported EBIT of $6.64M in Q1 2026.
How has CTEV's EBIT changed year-over-year?
CTEV's EBIT decreased by 31.9% year-over-year, from $9.74M to $6.64M.
What is the long-term trend for CTEV's EBIT?
Over 4 years (2021 to 2025), CTEV's EBIT has grown at a -47.7% compound annual growth rate (CAGR), from $386.12M to $28.88M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.